265 related articles for article (PubMed ID: 19654036)
41. Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.
Neri N; Avilés A; Cleto S; Díaz N; Talavera A; García EL; Díaz-Maqueo JC
J Hematother Stem Cell Res; 2001 Oct; 10(5):669-74. PubMed ID: 11672513
[TBL] [Abstract][Full Text] [Related]
42. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
Degliantoni G; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
[TBL] [Abstract][Full Text] [Related]
43. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
Giarratana MC; Gorin NC; Douay L
Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
[TBL] [Abstract][Full Text] [Related]
44. Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiation.
Carè A; Valtieri M; Mattia G; Meccia E; Masella B; Luchetti L; Felicetti F; Colombo MP; Peschle C
Oncogene; 1999 Mar; 18(11):1993-2001. PubMed ID: 10208421
[TBL] [Abstract][Full Text] [Related]
45. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
Bone Marrow Transplant; 2004 Apr; 33(7):721-8. PubMed ID: 14743200
[TBL] [Abstract][Full Text] [Related]
46. Variations in committed stem cells (CFU-GM and CFU-TL) in the peripheral blood of cancer patients treated by sequential combination chemotherapy for breast cancer.
Rusé-Riol F; Legros M; Bernard D; Chassagne J; Clavel H; Ferriere JP; Chollet P; Plagne R
Cancer Res; 1984 May; 44(5):2219-24. PubMed ID: 6713410
[TBL] [Abstract][Full Text] [Related]
47. [Follicular lymphoma in two brothers].
Asahi A; Okamoto S; Matsushita H; Hattori Y; Takayama N; Ikeda Y
Rinsho Ketsueki; 2001 May; 42(5):408-13. PubMed ID: 11452461
[TBL] [Abstract][Full Text] [Related]
48. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].
Lamana M; Fernández-Rañada JM
Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583
[TBL] [Abstract][Full Text] [Related]
49. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product support.
Sefcick A; Byrne JL; Russell NH
Bone Marrow Transplant; 2000 Nov; 26(10):1140-1. PubMed ID: 11108322
[No Abstract] [Full Text] [Related]
50. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
51. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
[TBL] [Abstract][Full Text] [Related]
52. [Effect of beta-interleukin on the content and proliferation of hemopoietic precursor cells in intact and irradiated long-term cultures of the bone marrow].
Lebedev VG; Moroz BB; Deshevoĭ IuB
Patol Fiziol Eksp Ter; 2002; (4):2-4. PubMed ID: 12638418
[TBL] [Abstract][Full Text] [Related]
53. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Domenech J; Linassier C; Gihana E; Dayan A; Truglio D; Bout M; Petitdidier C; Delain M; Petit A; Brémond JL
Blood; 1995 Jun; 85(11):3320-7. PubMed ID: 7756665
[TBL] [Abstract][Full Text] [Related]
54. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
56. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
57. Stem cell defects after cytoreductive therapy in man.
Schreml W; Lohrmann HP; Anger B
Exp Hematol; 1985; 13 Suppl 16():31-42. PubMed ID: 2985415
[TBL] [Abstract][Full Text] [Related]
58. Excretion of Ascaris lumbricoides during total body irradiation.
Jurcic JG; Koll B; Brown AE; Crown JP; Yahalom J; Gulati SC
Bone Marrow Transplant; 1994 Apr; 13(4):491-3. PubMed ID: 8019476
[TBL] [Abstract][Full Text] [Related]
59. Long-term marrow cultures from mice with busulfan-induced chronic latent aplasia.
Halka KG; Caro J; Erslev AJ
J Lab Clin Med; 1987 Jun; 109(6):698-705. PubMed ID: 3585143
[TBL] [Abstract][Full Text] [Related]
60. Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Sarris AH; Jiang Y; Tsimberidou AM; Thomaides A; Rassidakis GZ; Ford RJ; Medeiros LJ; Cabanillas F; McLaughlin P
Semin Oncol; 2002 Feb; 29(1 Suppl 2):48-55. PubMed ID: 11842389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
